Igm Biosciences, Inc.

Igm Biosciences A/s

Beatrice Tien-Yi Wang

Bruce Alan Keyt

Ramesh Baliga

Max Allen Schwarzer

Fen Zhang

Omar Duramad

This disclosure provides pentameric and hexameric CD20 binding molecules and methods of using such molecules to direct complement-mediated, T-cell-mediated, or both complement-mediated and T-cell-mediated killing of CD20-expressing cells.

Multimeric bispecific binding molecules specific for CD20 and CD3

This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using such binding molecules to direct apoptosis-mediated killing of TNF receptor-expressing cells.

Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof

Tumor necrosis factor (TNF) superfamily receptor IgM antibodies and uses thereof

Growing community of inventors

Mountain View, CA, United States of America

Beatrice Tien-Yi Wang